Stay updated on Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    New revision entry v3.4.3 is added and v3.4.2 is removed from the study record history.
    Difference
    0.1%
    Check dated 2026-03-11T17:02:20.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history. Notices about government funding and operating status were removed.
    Difference
    0.8%
    Check dated 2026-02-11T02:07:35.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A site-wide funding-status notice was added and the record history shows Revision v3.4.1, replacing Revision v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-03T23:52:46.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    UI updates include a new Show glossary option and explanations of the color-coded change highlights (green for additions and red for deletions) with a new revision tag (v3.4.0) visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-27T23:41:29.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    A new revision entry (v3.3.4) was added to the history and the previous revision (v3.3.3) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:22:02.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the record history and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer. These updates affect metadata and footer content rather than study details or workflows.
    Difference
    0.2%
    Check dated 2025-12-23T08:29:02.000Z thumbnail image

Stay in the know with updates to Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.